Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Personalized treatment plans are important for people with alopecia areata.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

CD2 might be a new treatment target for patchy alopecia areata.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

A new method was created to analyze certain chemicals in the urine of alopecia areata patients, revealing they have higher metanephrine content. This method can also be used for other related diseases.

Higher CRBP1 levels are linked to more severe alopecia areata.